Stifel Financial Corp Tekla Life Sciences Investors Transaction History

Stifel Financial Corp

  • $106 Billion
  • Q3 2025

A detailed history of Stifel Financial Corp transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Stifel Financial Corp holds 21,229 shares of HQL stock, worth $353,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,229
Previous 20,979 1.19%
Holding current value
$353,462
Previous $268,000 22.76%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$12.76 - $15.51 $3,190 - $3,877
250 Added 1.19%
21,229 $329,000
Q2 2025

Aug 14, 2025
SELL
$10.87 - $13.02 $17,250 - $20,662
-1,587 Reduced 7.03%
20,979 $268,000
Q1 2025

May 13, 2025
SELL
$12.69 - $14.36 $73,284 - $82,929
-5,775 Reduced 20.38%
22,566 $286,000
Q4 2024

Feb 13, 2025
BUY
$13.12 - $15.25 $149,279 - $173,514
11,378 Added 67.08%
28,341 $371,000
Q3 2024

Nov 14, 2024
SELL
$14.26 - $15.78 $39,215 - $43,395
-2,750 Reduced 13.95%
16,963 $255,000
Q2 2024

Aug 13, 2024
SELL
$12.79 - $14.27 $57,913 - $64,614
-4,528 Reduced 18.68%
19,713 $279,000
Q1 2024

May 13, 2024
SELL
$13.38 - $14.33 $55,192 - $59,111
-4,125 Reduced 14.54%
24,241 $330,000
Q4 2023

Feb 12, 2024
SELL
$11.35 - $13.6 $243,457 - $291,720
-21,450 Reduced 43.06%
28,366 $381,000
Q3 2023

Nov 13, 2023
SELL
$12.38 - $13.69 $50,881 - $56,265
-4,110 Reduced 7.62%
49,816 $621,000
Q2 2023

Aug 14, 2023
SELL
$13.13 - $14.17 $59,085 - $63,765
-4,500 Reduced 7.7%
53,926 $730,000
Q1 2023

May 12, 2023
SELL
$13.37 - $14.94 $244,510 - $273,222
-18,288 Reduced 23.84%
58,426 $813,000
Q4 2022

Feb 13, 2023
BUY
$13.55 - $15.23 $36,625 - $41,166
2,703 Added 3.65%
76,714 $1.09 Million
Q3 2022

Nov 14, 2022
SELL
$13.39 - $16.31 $8,301 - $10,112
-620 Reduced 0.83%
74,011 $1.01 Million
Q2 2022

Aug 15, 2022
BUY
$13.11 - $17.02 $2,543 - $3,301
194 Added 0.26%
74,631 $1.06 Million
Q1 2022

May 13, 2022
BUY
$15.35 - $19.29 $15,165 - $19,058
988 Added 1.35%
74,437 $1.23 Million
Q4 2021

Feb 14, 2022
BUY
$18.5 - $21.59 $12,228 - $14,270
661 Added 0.91%
73,449 $1.41 Million
Q3 2021

Nov 15, 2021
SELL
$20.27 - $22.67 $11,432 - $12,785
-564 Reduced 0.77%
72,788 $1.51 Million
Q2 2021

Aug 13, 2021
SELL
$19.14 - $21.44 $29,705 - $33,274
-1,552 Reduced 2.07%
73,352 $1.57 Million
Q1 2021

May 14, 2021
SELL
$19.31 - $22.07 $281,752 - $322,023
-14,591 Reduced 16.3%
74,904 $1.48 Million
Q4 2020

Feb 12, 2021
BUY
$16.8 - $20.21 $1.21 Million - $1.45 Million
71,751 Added 404.37%
89,495 $1.77 Million
Q3 2020

Nov 16, 2020
SELL
$16.71 - $19.06 $13,083 - $14,923
-783 Reduced 4.23%
17,744 $312,000
Q2 2020

Aug 14, 2020
SELL
$14.22 - $18.38 $34,398 - $44,461
-2,419 Reduced 11.55%
18,527 $332,000
Q1 2020

May 14, 2020
BUY
$12.22 - $17.99 $39,922 - $58,773
3,267 Added 18.48%
20,946 $313,000
Q4 2019

Feb 13, 2020
SELL
$14.63 - $17.84 $1,799 - $2,194
-123 Reduced 0.69%
17,679 $308,000
Q3 2019

Nov 13, 2019
BUY
$15.09 - $17.09 $7,545 - $8,545
500 Added 2.89%
17,802 $269,000
Q2 2019

Aug 14, 2019
SELL
$15.54 - $17.47 $7,008 - $7,878
-451 Reduced 2.54%
17,302 $291,000
Q1 2019

May 14, 2019
BUY
$15.5 - $17.9 $3,596 - $4,152
232 Added 1.32%
17,753 $304,000
Q4 2018

Feb 13, 2019
SELL
$13.99 - $20.35 $144,069 - $209,564
-10,298 Reduced 37.02%
17,521 $265,000
Q3 2018

Nov 13, 2018
BUY
$18.89 - $20.49 $19,626 - $21,289
1,039 Added 3.88%
27,819 $569,000
Q2 2018

Aug 14, 2018
SELL
$18.13 - $19.4 $19,380 - $20,738
-1,069 Reduced 3.84%
26,780 $503,000
Q1 2018

May 11, 2018
BUY
$18.92 - $21.52 $217,807 - $247,738
11,512 Added 70.47%
27,849 $533,000
Q4 2017

Feb 14, 2018
SELL
$18.31 - $22.24 $103,634 - $125,878
-5,660 Reduced 25.73%
16,337 $321,000
Q3 2017

Nov 13, 2017
BUY
$20.12 - $21.88 $442,579 - $481,294
21,997
21,997 $0

Others Institutions Holding HQL

# of Institutions
91
Shares Held
9.39M
Call Options Held
0
Put Options Held
0
View Full List

About TEKLA LIFE SCIENCES INVESTORS

HQL Quotes by TradingView
  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email